Dana-Farber Cancer Institute /ID# 222174

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Subcutaneous (SC) Bortezomib and Oral Dexamethasone Tablet and to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple Myeloma — Stopped early